EjsoPub Date : 2024-10-09DOI: 10.1016/j.ejso.2024.108751
I T Rubio, Wyld Lynda
{"title":"Multidisciplinary team meeting (MDT) in cancer care: All that glitters is not gold.","authors":"I T Rubio, Wyld Lynda","doi":"10.1016/j.ejso.2024.108751","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.108751","url":null,"abstract":"","PeriodicalId":11522,"journal":{"name":"Ejso","volume":" ","pages":"108751"},"PeriodicalIF":3.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142460692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Surgical patterns of care of pancreatic cancer. A French population-based study.","authors":"Guillaume Goebel, Valérie Jooste, Florence Molinie, Pascale Grosclaude, Anne-Sophie Woronoff, Arnaud Alves, Véronique Bouvier, Jean-Baptiste Nousbaum, Sandrine Plouvier, Leila Bengrine-Lefevre, Thomas Rabel, Anne-Marie Bouvier","doi":"10.1016/j.ejso.2024.108748","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.108748","url":null,"abstract":"<p><strong>Introduction: </strong>Surgical resection is the standard recommended treatment in localized pancreatic cancer. The benefit of neoadjuvant chemotherapy is still debated. The aim of this population-based study was to describe the pancreatic cancer surgical management.</p><p><strong>Material and methods: </strong>An observational real-world study from the French Network of Cancer Registries sampled 638 pancreatic adenocarcinomas diagnosed in 2019. Characteristics of patients, tumours and recommended and administered treatments were collected. Operability of the patients and resectability of the tumours were described. A multivariate logistic regression was used to identify factors associated with the probability of having surgical resection.</p><p><strong>Results: </strong>Among the 263 (41 %) patients with M0 pancreatic adenocarcinomas, 202 patients (77 %) were considered operable and 157 (60 %) also had a tumour considered resectable. Upfront resection was recommended for 68 % and resection after neoadjuvant chemotherapy for 32 % of these patients. Among operable patients with resectable tumour, 36 % underwent upfront R0 resection, and 15 % achieved R0 resection following neoadjuvant chemotherapy. Eventually, among M0 pancreatic adenocarcinomas, age over 80 years (OR<sub>≥80 years vs < 65 years</sub>: 0.16 [0.06-0.39], p < 0.001) and WHO performance status over 0 (OR<sub>1-2 vs 0</sub>: 0.43 [0.24-0.79], p = 0.013) decreased the odds of having resection. R0 surgical resection was achieved in 61 % of patients selected for upfront surgical recommendation, and 29 % of those selected for a prior neoadjuvant chemotherapy.</p><p><strong>Conclusion: </strong>In a non-selected population, one-third of patients with localized pancreatic cancer had a complete R0 surgical resection. Neoadjuvant chemotherapy did not achieve a resection rate similar to that of patients selected for upfront surgical indication.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":" ","pages":"108748"},"PeriodicalIF":3.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142460706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EjsoPub Date : 2024-10-09DOI: 10.1016/j.ejso.2024.108750
Ume Aiman, Umer Bin Shahzad
{"title":"Harnessing inflammatory markers to predict and prevent post-gastric surgery infections: A cost-saving approach.","authors":"Ume Aiman, Umer Bin Shahzad","doi":"10.1016/j.ejso.2024.108750","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.108750","url":null,"abstract":"","PeriodicalId":11522,"journal":{"name":"Ejso","volume":" ","pages":"108750"},"PeriodicalIF":3.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142497133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Feasibility of intraoperative assessment of STAS in pathologic stage 1 lung adenocarcinomas in Chinese patients.","authors":"FangPing Xu, ZhiHua Liu, JinHai Yan, Lixu Yan, ZhenBin Qiu, Yan Ge, ShanShan Lv, WenZhao Zhong","doi":"10.1016/j.ejso.2024.108747","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.108747","url":null,"abstract":"<p><strong>Background: </strong>Intraoperative assessment of tumor spread through air spaces (STAS) in early-stage lung adenocarcinomas (ADC) has been proposed to stratify patients for surgical management. However, data on the accuracy and reproducibility of detecting STAS on frozen sections (FS) and the prognostic value of STAS on FS remain limited and contradictory.</p><p><strong>Methods: </strong>We conducted a retrospective study on the feasibility of intraoperative assessment of STAS by comparing the STAS patterns identified on FS and permanent sections from 524 patients diagnosed with pathologic stage 1 lung ADC. We also evaluated the association between STAS with patients' clinicopathological characteristics and their postoperative survival outcomes.</p><p><strong>Results: </strong>STAS was identified in 117 out of 524 patients (22.3 %) on permanent sections. Patients with STAS identified on permanent sections experienced shorter progression-free survival (PFS; P = 0.042) and overall survival (OS; P = 0.005) compared to those without. STAS was identified in 87 out of 509 patients on FS. Patients with STAS detected on FS also had shorter PFS (P = 0.010) and OS (P < 0.001) than those without. Compared to permanent sections, STAS detection on FS yielded 66.7 % (74/111) sensitivity, 96.7 % (385/398) specificity, 85.1 % (74/87) positive predictive value, 91.2 % (385/422) negative predictive value, and 90.2 % (459/509) overall agreement. The kappa coefficient was 0.688 (P < 0.001).</p><p><strong>Conclusions: </strong>Our results from a large series of Chinese patients with stage 1 lung ADC indicated that STAS was associated with poorer survival outcomes on both FS and permanent sections. FS is a highly specific method for assessing STAS in stage 1 lung ADC, but caution is warranted regarding false-positive results.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":" ","pages":"108747"},"PeriodicalIF":3.5,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142460688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Necessity of splenectomy for antral-type scirrhous gastric cancer.","authors":"Yurina Yasui Fujisaki, Takaki Yoshikawa, Rei Ogawa, Masashi Nishino, Takeyuki Wada, Tsutomu Hayashi, Yukinori Yamagata, Masanori Tokunaga, Yusuke Kinugasa, Yasuyuki Seto","doi":"10.1016/j.ejso.2024.108734","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.108734","url":null,"abstract":"<p><strong>Background: </strong>Total gastrectomy with splenic hilar nodal dissection by splenectomy is frequently selected for resectable scirrhous gastric cancer (GC), irrespective of the whether it is of the antral or body type. However, whether splenectomy is necessary for antral-type scirrhous GC remains unclear.</p><p><strong>Methods: </strong>We retrospectively reviewed the data of patients treated at National Cancer Center Hospital in Japan between 2000 and 2018. We selected patients with type IV GC in which the predominant location could be identified, who received D2 or more total gastrectomy with splenectomy, and in whom R0 or R1 resection was achieved. The therapeutic value index was evaluated by multiplying the metastatic rate of each nodal station by the five-year overall survival (OS) rate of patients with metastasis to each node.</p><p><strong>Results: </strong>In total, 180 patients were included in this study (antral type, n = 19 [10.6 %]; body type, n = 161 [89.4 %]). Both types showed similar and frequent invasion of the greater curvature of the upper stomach. Metastasis to the splenic hilar nodes (#10) was not observed in the antral type (0/19) but was observed in the body type (35/161, 21.7 %); the difference was statistically significant (p = 0.027). The therapeutic value index of #10 was 0 in the antral type but was >7, the fourth highest, in the body type. The only nodes with an index >0 in the antral type were #4d, #3, #4sb, #6, #7, and #1.</p><p><strong>Conclusions: </strong>Splenectomy may therefore be unnecessary for antral-type scirrhous GC.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":" ","pages":"108734"},"PeriodicalIF":3.5,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142460693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EjsoPub Date : 2024-10-06DOI: 10.1016/j.ejso.2024.108738
Ye Wang , Zhen Pan , Shoufeng Li , Huajun Cai , Ying Huang , Jinfu Zhuang , Xing Liu , Xingrong Lu , Guoxian Guan
{"title":"Prediction and validation of pathologic complete response for locally advanced rectal cancer under neoadjuvant chemoradiotherapy based on a novel predictor using interpretable machine learning","authors":"Ye Wang , Zhen Pan , Shoufeng Li , Huajun Cai , Ying Huang , Jinfu Zhuang , Xing Liu , Xingrong Lu , Guoxian Guan","doi":"10.1016/j.ejso.2024.108738","DOIUrl":"10.1016/j.ejso.2024.108738","url":null,"abstract":"<div><h3>Background</h3><div>Precise evaluation of pathological complete response (pCR) is essential for determining the prognosis of patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiotherapy (NCRT) and can offer clues for the selection of subsequent treatment strategies. Most current predictive models for pCR focus primarily on pre-treatment factors, neglecting the dynamic systemic changes that occur during neoadjuvant chemoradiotherapy, and are constrained by low accuracy and lack of integrity.</div></div><div><h3>Purpose</h3><div>This study devised a novel predictor of pCR using dynamic alterations in systemic inflammation-nutritional marker indexes (SINI) during neoadjuvant therapy and developed a machine-learning model to predict pCR.</div></div><div><h3>Methods</h3><div>Two cohorts of patients with LARC from center one from 2012 to 2017 and from center two from 2020 to 2023 were integrated for analysis. This study compared dynamic changes in blood indexes before and after neoadjuvant therapy and surgical operation. A least absolute shrinkage and selection operator (LASSO) regression analysis was conducted to mitigate collinearity and identify key indexes, constructing the SINI. Univariate and multiple logistic regression analyses were used to identify the independent risk factors associated with pCR. Additionally, 10 machine learning algorithms were employed to develop predictive models to assess risk. The hyperparameters of the machine learning models were optimized using a random search and 10-fold cross-validation. The models were assessed by examining various metrics, including the area under the receiver operating characteristic curves (AUC), the area under the precision-recall curve (AUPRC), decision curve analysis, calibration curves, and the precision and accuracy of the internal and external validation cohorts. Additionally, Shapley's additive explanations (SHAP) were employed to interpret the machine learning models.</div></div><div><h3>Results</h3><div>The study cohort comprised 677 patients from the center one and 224 patients from the center two. Six key indexes were identified, and a predictive index, SINI, was constructed. Univariate and multiple logistic regression analyses revealed that SINI, clinical T-stage, clinical N-stage, tumor size, and the distance from the anal verge were independent risk factors for pCR in patients with LARC following NCRT. The mean AUC value of the extreme gradient boosting (XGB) model in the 10-fold cross-validation of the training set was 0.877. The XGB model demonstrated superior performance in the internal and external validation sets. Specifically, in the internal test set, the XGB model achieved an AUC of 0.86, AUPRC of 0.707, accuracy of 0.82, and precision of 0.80. In the external validation set, the XGB model exhibited an AUC of 0.83, AUPRC of 0.702, accuracy of 0.81, and precision of 0.81. Additionally, the predictions generated by the XGB model were a","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"50 12","pages":"Article 108738"},"PeriodicalIF":3.5,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142423513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EjsoPub Date : 2024-10-05DOI: 10.1016/j.ejso.2024.108745
Simone Conci , Giovanni Catalano , Wojciech Polak , Francesco Ardito , Mario De Bellis , Edoardo Poletto , Caterina Mele , Laura Alaimo , Felice Giuliante , Bas Groot Koerkamp , Andrea Ruzzenente
{"title":"The preoperative recurrence score: Predicting early recurrence in peri-hilar cholangiocarcinoma","authors":"Simone Conci , Giovanni Catalano , Wojciech Polak , Francesco Ardito , Mario De Bellis , Edoardo Poletto , Caterina Mele , Laura Alaimo , Felice Giuliante , Bas Groot Koerkamp , Andrea Ruzzenente","doi":"10.1016/j.ejso.2024.108745","DOIUrl":"10.1016/j.ejso.2024.108745","url":null,"abstract":"<div><h3>Introduction</h3><div>Despite advances in surgical techniques, the rate of early recurrence in perihilar cholangiocarcinoma (PCC) remains high. We sought to develop the Preoperative Recurrence Score (PRS), a model to estimate the risk of early recurrence after resection based on preoperative radiological characteristics.</div></div><div><h3>Materials and methods</h3><div>Data of patients who underwent surgery for PCC were retrospectively collected, and preoperative imaging was reviewed to assess tumor characteristics. A model to assess the risk of early recurrence based on preoperative radiologic characteristics was internally developed and externally validated on two cohorts of patients from two European major hepatobiliary surgery referral centers.</div></div><div><h3>Results</h3><div>A total of 215 patients among three different patient cohorts were included in the study. Tumor size ≥18 mm (HR 2.70, 95 % CI 1.48–4.92, p = 0.001), macroscopic portal vein involvement (HR 2.28, 95%CI 1.19–4.34, p = 0.013), hepatic arteries involvement (HR 2.44, 95%CI 1.26–4.71, p = 0.008), and presence of suspicious lymph nodes (HR 1.98, 95%CI 1.02–3.83, p = 0.043) were significantly associated with recurrence-free survival (RFS). The model showed excellent discrimination both on the internal (AUC 0.83) and external validation cohorts (external 1: AUC 0.84; external 2: AUC 0.70). High PRS was associated with worse RFS among all three cohorts, with a 1-year recurrence probability of 80.1 %, 100.0 %, and 54.2 % in the internal and external validation cohorts 1 and 2, respectively.</div></div><div><h3>Conclusions</h3><div>The PRS is a simple tool that can accurately assess the risk of early recurrence in patients with PCC. Up-front surgery should be carefully evaluated in patients with high PRS, as it could result in a futile resection.</div></div>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"50 12","pages":"Article 108745"},"PeriodicalIF":3.5,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EjsoPub Date : 2024-10-05DOI: 10.1016/j.ejso.2024.108740
Luca G Campana, Francesca Tauceri, Joana Bártolo, Sarah Calabrese, Joy Odili, Giulia Carrara, Victor Farricha, Dario Piazzalunga, Kriszta Bottyán, Kamal Bisarya, Matteo Mascherini, James A Clover, Serena Sestini, Maša Bošnjak, Erika Kis, Fabrizio Fantini, Piero Covarelli, Matteo Brizio, Leela Sayed, Carlo Cabula, Rosanna Careri, Tommaso Fabrizio, Klaus Eisendle, Alastair MacKenzie Ross, Hadrian Schepler, Lorenzo Borgognoni, Gregor Sersa, Sara Valpione
{"title":"Treatment strategies with electrochemotherapy for limb in-transit melanoma: Real-world outcomes from a European, retrospective, cohort study.","authors":"Luca G Campana, Francesca Tauceri, Joana Bártolo, Sarah Calabrese, Joy Odili, Giulia Carrara, Victor Farricha, Dario Piazzalunga, Kriszta Bottyán, Kamal Bisarya, Matteo Mascherini, James A Clover, Serena Sestini, Maša Bošnjak, Erika Kis, Fabrizio Fantini, Piero Covarelli, Matteo Brizio, Leela Sayed, Carlo Cabula, Rosanna Careri, Tommaso Fabrizio, Klaus Eisendle, Alastair MacKenzie Ross, Hadrian Schepler, Lorenzo Borgognoni, Gregor Sersa, Sara Valpione","doi":"10.1016/j.ejso.2024.108740","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.108740","url":null,"abstract":"<p><strong>Background: </strong>This study analysed treatment strategies with electrochemotherapy (ECT) in melanoma with limb in-transit metastases (ITM).</p><p><strong>Methods: </strong>We audited AJCC v.8 stage IIIB-IIID patients treated across 22 centres (2006-2020) within the International Network for Sharing Practices of ECT (InspECT).</p><p><strong>Results: </strong>452 patients were included, 58 % pre-treated (93 % had lower limb ITM, 44 % had ≤10 metastases [median size 1.5 cm]. Treatment strategies included first-line ECT (n = 145, 32 %), ECT with concurrent locoregional/systemic treatment (n = 163, 36 %), and salvage ECT (n = 144, 32 %). The objective response rate was 63 % (complete response [CR], 24 %), increasing to 74 % (CR, 39 %) following retreatment (median two ECT, range 1-8). CR rate in treatment-naïve and pre-treated patients was 50 % vs 32 % (p < 0.001). Bleomycin de-escalation was associated with lower CR (p = 0.004). Small tumour number and size, hexagonal electrode, retreatment, and post-ECT skin ulceration predicted response in multivariable analysis. At a median follow-up of 61 months, local and locoregional recurrence occurred in 55 % and 81 % of patients. Median local progression-free, new lesions-free, and regional recurrence-free survival were 32.9, 6.9, and 7.7 months. Grade-3 toxicity was 15 %. Concurrent treatment and CR correlated with improved regional control and survival. Concomitant checkpoint inhibition did not impact toxicity or survival outcomes. The median overall survival was 5.7 years.</p><p><strong>Conclusions: </strong>Among patients with low-burden limb-only ITM, standard-dose bleomycin ECT results in durable local response. Treatment naivety, low tumour volume, hexagonal electrode application, retreatment, and post-ECT ulceration predict response. CR and concurrent treatment correlate with improved regional control and survival outcomes. Combination with checkpoint inhibitors is safe but lacks conclusive support.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":" ","pages":"108740"},"PeriodicalIF":3.5,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142497170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EjsoPub Date : 2024-10-04DOI: 10.1016/j.ejso.2024.108742
Klejda Harasani, Mariela Vasileva-Slaveva, Angel Yordanov, Irina Tripac, Jean Calleja-Agius
{"title":"Systematic review of cost-effectiveness studies on cervical cancer screening across Europe.","authors":"Klejda Harasani, Mariela Vasileva-Slaveva, Angel Yordanov, Irina Tripac, Jean Calleja-Agius","doi":"10.1016/j.ejso.2024.108742","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.108742","url":null,"abstract":"<p><strong>Introduction: </strong>Cervical cancer (CC) is a type of cancer with poor prognosis when diagnosed in advanced stage with a big socioeconomic burden. The incidence rates have wide variations among European countries depending on the implementation or not of screening, vaccination programs and the human development index (HDI). Most studies on cost-effectiveness of CC screening programs are carried out in countries with a high HDI, however more recent reviews of screening approaches are coming from countries with lower HDI aiming to identify the best screening strategies. Our study aims to identify which are the currently applied and most cost-effective strategies of CC screening in Europe.</p><p><strong>Materials and methods: </strong>This is a systematic review conducted in three different databases (PubMed, Scopus and ScienceDirect) and reported following the PRISMA guidelines. General key terms for all databases were the following: cost-effectiveness, cervical cancer, screening, Europe. We included studies in English, Italian, Spanish and Bulgarian, published in the last 25 years, reporting data on cost-effectiveness of CC screening, costs and outcome measures. The methodological quality of the articles was evaluated with a standardized tool.</p><p><strong>Results: </strong>A total of 262 studies were identified and 22 studies were included in the final analysis. In 90.1 % of the economic studies, the new screening strategy was shown to be more cost-effective compared to the current one or compared to no screening. The optimal strategy mostly involved primary HPV testing, combined with cytology or as stand-alone screening technique. Several scenarios differing on starting age and periodicities for CC screening, combination of techniques and triage, were found to be cost-effective and below the willingness to pay (WTP) threshold. The methodology of all included studies was assessed from 10 to 11 on the JBI standardized tool and Drummond 11-point checklist.</p><p><strong>Conclusion: </strong>Numerous cost-effective options for CC screening in different European countries were identified in this systematic review. HPV testing, with or without cytology, mainly starting at 30 years of age and repeated every 5 years or more was the most cost-effective technique. Future studies should focus on the most appropriate CC screening approach for each context and setting, also considering HPV vaccination in Europe.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":" ","pages":"108742"},"PeriodicalIF":3.5,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EjsoPub Date : 2024-10-04DOI: 10.1016/j.ejso.2024.108744
Mariano Catello Di Donna, Giuseppe Cucinella, Vincenzo Giallombardo, Giuseppina Lo Balbo, Vito Andrea Capozzi, Giulio Sozzi, Natalina Buono, Letizia Borsellino, Andrea Giannini, Antonio Simone Laganà, Giovanni Scambia, Vito Chiantera
{"title":"Surgical outcomes and morbidity in open and videoendoscopic inguinal lymphadenectomy in vulvar cancer: A systematic review and metanalysis\".","authors":"Mariano Catello Di Donna, Giuseppe Cucinella, Vincenzo Giallombardo, Giuseppina Lo Balbo, Vito Andrea Capozzi, Giulio Sozzi, Natalina Buono, Letizia Borsellino, Andrea Giannini, Antonio Simone Laganà, Giovanni Scambia, Vito Chiantera","doi":"10.1016/j.ejso.2024.108744","DOIUrl":"https://doi.org/10.1016/j.ejso.2024.108744","url":null,"abstract":"<p><strong>Introduction: </strong>Surgical evaluation of inguinal lymph nodes is essential to correctly guide the adjuvant treatment of vulvar cancer patients. Open inguinal lymphadenectomy (OIL) approach is the preferred route, while the videoendoscopic inguinal lymphadenectomy (VEIL) seems to be associated with better results. This meta-analysis aimed to compare the surgical outcomes of OIL vs VEIL in vulvar cancer.</p><p><strong>Methods: </strong>The meta-analysis was conducted according to the PRISMA guideline. The search string included the following keywords: \"(vulvar cancer) AND ((inguinal) OR (femoral)) AND ((lymph node dissection) OR (lymphadenectomy))\". Three double-blind researchers independently extracted data.</p><p><strong>Results: </strong>Seventeen studies were considered eligible for the analysis. Seven studies were included in the OIL group and ten studies in the VEIL group. A total of 372 groins were included in OIL group and 197 groins in VEIL group. 153 groins (41.1 %) in the OIL group and 25 groins (12.6 %) in the VEIL group developed major complications. The analysis of all lymphatic and wound complications showed that VEIL had a lower rate of lymphatic and wound complications. Estimated blood loss (p = 0.4), hospital stay (p = 0.18), time of drainage (p = 0.74), number of lymph node excised (p = 0.74) did not show significant difference between the two approaches.</p><p><strong>Conclusions: </strong>VEIL route may be a valid alternative to OIL route with no differences in terms of surgical outcomes, except for operative time that is shorter for OIL. Future analysis of randomized controlled trials in this specific patient population are warranted to confirm these results.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":" ","pages":"108744"},"PeriodicalIF":3.5,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142460705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}